Hereditary Disease Foundation (HDF) logo
HDF Transformative Research Awards

HDF Transformative Research Award

Funds high-impact collaborative Huntington disease teams tackling complex mechanisms and novel therapeutic strategies with advanced team science.

The Hereditary Disease Foundation (HDF) Transformative Research Award is the foundation's largest grant instrument, designed for multi-investigator collaborative teams pursuing exceptional, high-risk research into Huntington's disease mechanisms and therapeutic strategies. HDF, founded in 1968 and based in New York, established the program to fund work that would be ineligible for incremental gran

Transformational Huntington's disease research with exceptional novelty, prioritising somatic repeat instability, cellular and biochemical disease predictors, and disease-modifying therapeutic strategies.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.14 May 2027
Decision timeiTypical time from the deadline to the funder's decision.
Project durationiHow long the funded work is expected to run.12–24 months
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see what winners did

Sign up free to see where teams trip up

Last verified: 24 Jul 2026Source: hdfoundation.org